Morihito Okada

3PUBLICATIONS
32CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Nov 06, 2025
Plasminogen Activator Inhibitor-1 Mediates Tolerance to Anti-PD-1 Immunotherapy in Non-Small Cell Lung Cancer.

Masahiko Sumii, Takeshi Masuda, Kiyofumi Shimoji

|Apr 17, 2023
FOXA2 Cooperates with Mutant KRAS to Drive Invasive Mucinous Adenocarcinoma of the Lung.

Koichi Tomoshige, William D Stuart, Iris M Fink-Baldauf

|Mar 16, 2022
Three-Year Follow-Up and Response-Survival Relationship of Nivolumab in Previously Treated Patients with Advanced Esophageal Squamous Cell Carcinoma (ATTRACTION-3).

Morihito Okada, Ken Kato, Byoung Chul Cho

Pageof 1